C
ORONARY HEART DISEASE (CHD) is the leading killer of women in the United States, causing about 1 in every 4 female deaths. And though heart disease mortality has declined significantly since its peak in the 1950s, it has declined less in women. In the mid-1990s, the scientific community began to explore the effects of depression on those with CHD. Approximately 12 million women in the United States are diagnosed with depression every year, and 1 in every 8 women will experience clinical depression in her lifetime. Research suggests that women experience depression at a rate of 2:1 compared 1 Depression has significant health ramifications in the CHD population. In 2014, the American Heart Association published a scientific statement elevating depression to the status of risk factor for poor prognosis among patients with acute coronary syndrome. 2 There is strong evidence for increased negative outcomes among those who develop depressive symptoms following a cardiac event, including increased morbidity and mortality. 2 Evidence from work on acute coronary syndrome and acute myocardial infarction (MI) has demonstrated that women and men do not necessarily have the same CHD experiences. In fact, recent work has demonstrated that women experience more microvascular disease and stress-induced ischemia than men. 3, 4 However, women are underrepresented in CHD research. The continued lack of women in CHD research, coupled with lack of data analysis by gender in much of the published literature, has meant that even though women experience twice as much depression as men, their depressive symptom experiences remain largely invisible.
While women's depressive symptoms in this population have been explored, our review of the literature suggests that limited research has been done to understand and clarify the conceptual meaning of depression in women with CHD. From this review, it appears that the conceptualization of depression in women with CHD is widely variable, and that this variability arises from the way the concept of depression is operationalized, that is, the instruments used to measure the concept. The literature search conducted for this article yielded 16 different instruments used to operationalize depression-from a 2-question screening instrument to the criterion standard Composite International Diagnostic Interview (see Table 1 ). Because different instruments ask different questions and not all instruments include questions about certain symptoms of depression (such has somatic symptoms), the actual concept of depression in women with CHD may not be captured by the instrument being used to measure the concept. Therefore, research on women with CHD and comorbid depression would benefit by a concept analysis of depression in women with CHD.
Concept analysis, according to Walker and Avant, 5 is a "process of examining the basic elements of a concept . . . result [ing] in a precise operational definition that by its very nature increases the validity of the construct."
(p158) Concept analysis can be used for various purposes, including refining ambiguity of a concept in a theory, clarification of an overused or vague concept, construction of a research instrument, or evaluation of existing research instruments.
AIMS
The aim of this concept analysis of depression associated with a diagnosis of CHD in women is concept clarification. Concept analysis for the purpose of concept clarification is appropriate when a concept has a large body of literature defining and describing it, including quantitative instruments for measuring the concept, but the concept is measured using different variables and is applied inconsistently in the research. 6 Clarifying the concept of depression in women with CHD is necessary for a better understanding of women's experiences so that accurate diagnoses can lead to more timely and appropriate interventions. determining the aim or purpose of the analysis; (3) identifying all uses of the concept; (4) determining the concept's defining attributes; (5) identifying a model case; (6) identifying additional cases (borderline and contrary cases); (7) identifying antecedents and consequences; and (8) defining empirical referents.
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To begin this concept analysis, the basic concept of depression was identified, aims determined, and its use in both medical and nonmedical settings explored. A literature search from 1990 to August 15, 2018, of English language articles was then performed to explore the concept of depression specifically in women with CHD. A PubMed search utilizing the terms coronary heart disease, depression, and sex factors or sex differences, with the filters female, human, and English language yielded 100 articles. Because this concept analysis focuses specifically on CHD (rather than the larger concept of cardiovascular disease), articles related to heart failure, stroke, and peripheral vascular disease were removed. Articles describing depression as a risk factor for the development of CHD were also excluded. After these exclusions, 40 articles remained. These articles were used to define the concept's critical attributes, antecedents, and consequences; cases were constructed using the concept; and empirical referents identified. Finally, the use of this concept in future research and clinical practice is discussed.
Uses of the concept
The word "depression" has several different meanings and uses. Apart from its use in common parlance, usually to indicate a low mood, it is also used in mathematics, astronomy, meteorology, economics, and health care. Merriam-Webster's online dictionary lists several definitions: the angular distance of a celestial object below the horizon; the size of an angle of depression; a pressing down, such as a depression of the tab key on a keyboard; a state of feeling sad; a place or part that is lower than the surrounding area; and a low, as in a tropical depression, or a long period of low general economic activity marked especially by rising levels of unemployment.
The National Institute of Mental Health gives this definition of depression:
Hare and Davis, 8 who created the Cardiac Depression Scale to assess for depression in the cardiac population, used the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV) 9 criteria for "adjustment disorder with depressive symptoms" as their definition of depression. According to DSM-IV, "adjustment disorder with depressive symptoms" is defined as: "the development of emotional or behavioral symptoms in response to an identifiable stressor(s) occurring within 3 months of the onset of the stressor(s)," creating distress in excess of what would typically be expected or significant impairment in social or work functioning. These symptoms do not exceed 6 months in duration once the stressor is over.
The DSM, published by the American Psychiatric Association, provides the medical diagnostic criteria for depression as a mental health disorder. The DSM-V, the most recent edition of the manual, lists 8 different diagnoses that fall under the category of depressive disorders: disruptive mood dysregulation disorder, major depressive disorder (MDD), persistent depressive disorder (dysthymia), premenstrual dysphoric disorder, substance/medication-induced depressive disorder, depressive disorder due to another medical condition, other specified depressive disorder, and unspecified depressive disorder. Although there are significantly different components to each of these 8 diagnoses, they all share common core features: sadness, emptiness, or irritable mood, accompanied by somatic and cognitive changes that significantly impact an individual's ability to function. Per DSM-V criteria, a diagnosis of MDD (the diagnosis most researchers refer to when talking about depression in the CHD population) requires either depressed mood or loss of interest or pleasure (anhedonia) plus 3 to 4 of the other 7 core symptoms (for a total of at least 5 core symptoms) during a consecutive 2-week period. So-called "minor depression" (or "depressive episode with insufficient symptoms," defined under "other specified depressive disorders" in DSM-V) requires only a depressed affect and 1 of the 8 other core symptoms of MDD, with the same duration and distress or functional impairment as MDD to meet criteria.
More recently, Ormel and de Jonge 10 developed an integrative model of depression in the setting of CHD. Their model proposes 2 subtypes of depression: (1) cognitiveaffective (also called "typical"), characterized by depressed mood, anhedonia, negative feelings such as self-dislike and sense of failure, guilt, interpersonal sensitivity, and future pessimism; and (2) somatic/affective (also called "somatic"), characterized by fatigue, psychomotor agitation/retardation, sleep problems, aches and pains, appetite disturbance, weight disturbance, and work difficulty.
These authors are interested specifically in depression in women following a diagnosis of CHD (as opposed to depression as a precursor to its development). In the majority of studies looking at depression in individuals with CHD, the authors do not provide a conceptual definition of depression. Rather, depression is given an operational definition via the instrument used to assess it. Confusingly, this leads to numerous different operational definitions.
Operational definitions
The criterion standard for evaluating patients for depression is the structured clinical interview. 11 However, such interviews are usually rather lengthy (45-120 minutes) for research participants. Of the 40 articles reviewed for this article, only 2 used an interview to assess for depression. Therefore, most researchers rely on instruments that screen for depression rather than completing a diagnostic interview, and cutoff scores become a proxy for clinically significant depressive symptom burden. This makes these screening instruments of paramount importancethe symptoms included on the screening instrument become the operational definition of depression.
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The instruments used to assess depressive symptoms in the CHD population can be grouped into 3 categories on the basis of the symptoms included/excluded and the origins of their development: (1) instruments based on DSM criteria for depression that include somatic symptoms, (2) instruments that do not include somatic symptoms, and (3) instruments based on other criteria. Because of the multiple instruments used, 3 commonly used instruments will be discussed as exemplars of the 3 categories. Table 1 lists all depression assessment instruments found in the literature search, based on the aforementioned categories.
Instruments based on DSM criteria that include somatic symptoms
The first category of depression scales is those that were created on the basis of the accepted criteria for MDD at the time of their creation and include both cognitive and somatic symptoms. The best example of this is the Beck Depression Inventory (BDI), originally published in 1961. Beck and his colleagues 12 created a depression measurement instrument by observing attitudes and symptoms displayed by depressed psychiatric inpatients and outpatients at 2 hospitals in Philadelphia, consulting the newly published DSM-I, and finally consolidating these observations into a 21-item questionnaire. The BDI-II, an update to the original scale, was published in 1996 in response to the publications of DSM-III-R and DSM-IV to make it more consistent with the current diagnostic criteria. Other scales found in this review that are based on DSM criteria and include both cognitive and somatic symptoms include the Center for Epidemiologic Studies Depression scale (CES-D) and its shorter version, the CESD-8, and the Patient Health Questionnaire 9-item (PHQ-9).
Instruments that do not include somatic symptoms
The second category of scales measuring depression does not include somatic symptoms. These were often developed to avoid measuring somatic symptoms that may have reflected physical rather than mental illness. The hallmark example of this category of scales is the Hospital Anxiety and Depression Scale (HADS). The HADS, developed by Zigmond and Snaith 13 from research conducted in general medical outpatient clinics and originally published in 1983 focused on anhedonia as the central concept of depression. Zigmond and Snaith 13 felt that there was no easy way to distinguish between physical symptoms rooted in a physical ailment and physical symptoms reflective of a mental illness. They wanted an easy way to detect mental illness in order to avoid a lengthy physical workup. So Zigmond and Snaith created an instrument where " . . . symptoms which might equally arise from somatic [physical] as from mental disease" were excluded. 13 This concern about inclusion of somatic symptoms (such as fatigue, changes in appetite, or sleep disturbance) measuring a physical rather than mental illness and subsequent overestimation of depression 13 is echoed in the more recently developed National Institutes of Health-sponsored PROMIS depression instruments, which also do not include any somatic depressive symptoms. Other assessment instruments, such as the PHQ-2 and the General Health Questionnaire 30-item, are the shortened version of longer instruments that have removed the somatic items.
Instruments based on other criteria
The last category of depression scales is based on some criteria other than DSM MDD criteria. The exemplar for this category is the Zung Self-Rating Depression Scale. Although DSM-I had been published in 1952, it was not widely used until DSM-III was published in 1980, representing "a veritable paradigm shift in psychiatry." 14 The Zung scale was created on the basis of combining the results of 3 separate "factor analyses" 15 Three broad domains were identifiedpervasive affect, physiological equivalents, Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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and psychological equivalents-and the most commonly found characteristics in the factor analyses were fitted into these domains and comprised the symptoms assessed by the scale. Subsequently, records of interviews with patients were reviewed and statements that seemed most representative of a particular symptom were chosen to create the scale. The final scale was a 20-item questionnaire. Other examples of instruments in this category include the Geriatric Depression Scale (based on the Research Diagnostic Criteria developed by the National Institute of Mental Health Psychobiology of Depression Collaborative Study, published in 1978), Gotland Scale of male depression (developed in 2002 with alcohol-dependent men, with questions about irritability, aggression, and alcohol use), and the General Health Questionnaire 60-item (developed in the 1970s for identifying minor psychiatric disorders in the general population), among others.
The importance of "minor" depressive symptoms
Strik and colleagues 16 argue that the use of self-report depression scales to screen for depression in clinical patients, such as those described previously, is justified only if they demonstrate high concurrent validity with DSM criteria for major and minor depression (italics added). In a study examining the sensitivity and specificity of 3 frequently used questionnaires for depression in MI patients, Strik et al 16 noted that optimum cutoff scores (the score that combines maximal sensitivity with optimal specificity on a receiver operating characteristics curve) for MI patients are below the generally accepted cutoff scores (which were determined using the population in which the instrument was originally designed and tested). The generally accepted cutoff scores would capture MDD but miss those with minor depression. The study by Doering et al 17 demonstrates this perfectly. Of the 75 women in their study, 7 (9.3%) met MDD criteria, while 20 (26.3%) met criteria for minor depression. In addition, if women experience a preponderance of somatic symptoms that are not captured on the depression scale being used, they will be underdiagnosed or missed altogether. Ketterer and colleagues 18 argued that there is a problem with the DSM-IV threshold in patients with CHD in that it is too high and likely to overlook patients with depression. That is, . . . MDD criteria appear to exclude patients who are at risk for adverse outcomes from CHD . . . . Furthermore, many other investigators have found "minor" depression to be predictive of CHD morbidity and mortality.
Defining attributes
Walker and Avant 5 describe the defining attributes of a concept as "a cluster of attributes that are most frequently associated with the concept . . . [and] functions very much like the criteria for making differential diagnoses in medicine." (p162) Several authors have argued that individuals with heart disease, and women with CHD in particular, experience more "somatic" symptoms than "cognitive" symptoms. [19] [20] [21] [22] Furthermore, low levels of depressive symptoms (ie, fewer symptoms than required to meet criteria for MDD) are not unusual in those with CHD and have also been associated with worse outcomes such as increased all-cause and cardiac mortality. 2 Examining specific symptoms as attributes of this concept, several studies have supported a group of symptoms as being the most common in women with CHD. These symptoms include dysphoria/sadness; self-dislike; tiredness/fatigue; loss of energy; sleep disturbances; appetite disturbances; concentration difficulties; indecisiveness; crying; and loss of interest in sex. 1, 17, 21, 22 Some of these symptoms are considered dimensions of the cognitive aspect of depression (dysphoria/sadness, indecisiveness, crying, and self-dislike) and some of these symptoms are considered dimensions of the somatic aspect of depression (tiredness/fatigue, appetite disturbance, loss of energy, sleep disturbance, and loss of interest in sex) (see Table 2 ). Frazier 21 in comparing men's and women's scores on the BDI-II and the Gotland Scale of Male Depression, found that women scored significantly higher than men on indecisiveness (BDI-II), crying (BDI-II), tiredness (BDI-II), loss of energy (BDI-II), inexplicable tiredness (Gotland Scale of Male Depression), sleep problems (Gotland Scale of Male Depression), changes in sleep patterns (BDI-II), loss of interest in sex (BDI-II), concentration difficulty (BDI-II), and changes in appetite (BDI-II).
In addition to women scoring higher on depressive symptoms overall compared with men in both studies, significantly more women in the study by Frazier et al 1 reported experiencing somatic symptoms (sleep disturbance, appetite disturbance, and/or fatigue) than men, and in the study by Grace et al, 21 women scored significantly higher on the "psychomotor fatigue" factor ("ie, somatic features") than men. The defining attributes delineated here must be present in any operationalized definition of depression in women with CHD. In other words, the screening instruments used in women with CHD must contain these attributes if we hope to adequately and accurately assess this population.
Model case
According to Walker and Avant, 5 a model case is one "that demonstrates all the defining attributes of the concept" (p163) -an exemplar. They may be found in the literature or created for the purposes of the concept analysis. The following is a model case for depression in women with CHD.
Marilyn is a 53-year-old divorced woman with a personal history of poorly controlled type II diabetes, hypertension, anxiety, and obesity who suffered an ST-elevation myocardial infarction (MI) 2 weeks ago. She was treated with an emergent heart catheterization, and 2 drug-eluting stents were placed at that time. Her father died of an MI at the age of 46 years, and her mother had a stroke at the age of 65 years. She is now a caregiver for her mother, who resides with her.
Marilyn has returned home from the hospital, but instead of feeling better, she finds that she is now always tired and has little to no energy. Although she knows that she should be attending cardiac rehabilitation (CR), she cannot bring herself to go. She is sleeping poorly and is unable to concentrate on the things she needs to get done. She has no appetite and forgets to eat. She has missed 2 weeks of work because of her MI and though she typically enjoyed her job, is now ambivalent about returning to work. She often finds herself lying on her bed crying, wondering how she is supposed to "take better care of herself," care for her mother, and go back to work when she cannot even get out of bed in the morning. She hates herself for not having managed her diabetes better, getting so fat and out of shape, and now having heart disease on top of everything else, and cannot imagine how she is ever going to manage.
This model case is a clear example of depression in a woman following a CHD diagnosis.
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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Additional cases Borderline case
A borderline case will have some but not all of the defining attributes of the concept.
Marilyn is a 53-year-old divorced woman with a personal history of poorly controlled type-II diabetes, hypertension, anxiety, and obesity who suffered an ST-elevation MI 2 weeks ago. She was treated with an emergent heart catheterization, and 2 drug-eluting stents were placed at that time. Her father died of an MI at the age of 46 years, and her mother had a stroke at the age of 65 years. She is now a caregiver for her mother, who resides with her.
Marilyn has returned home from the hospital and remains fatigued with little energy. She knows that attending CR is important and though she is tired, she forces herself to attend anyway. She is less afraid of exercising that she was at first and is sleeping better. Her appetite seems to be improving.
She has missed 2 weeks of work because of her MI and though she typically enjoyed her job, she is now ambivalent about returning. She is working hard at trying to do what she is supposed to be doing (such as, eating better, checking her blood sugars every morning, and remembering to take her medication every day) and take care of her mother as well.
Contrary case
A contrary case would not display the defining attributes of the concept.
Marilyn is a 53-year-old divorced woman with a personal history of poorly controlled type II diabetes, hypertension, anxiety, and obesity who suffered an ST-elevation MI 2 weeks ago. She was treated with an emergent heart catheterization, and 2 drug-eluting stents were placed at that time. Her father died of an MI at the age of 46 years, and her mother had a stroke at the age of 65 years. She is now a caregiver for her mother, who resides with her.
Marilyn has returned home from the hospital and has started attending CR. Although she still gets tired, she is feeling much better about how things are going now. She is sleeping well and her appetite is back. She has missed 2 weeks of work because of her MI and was initially apprehensive about returning but now is feeling more confident and is looking forward to returning once her doctor says it is OK. She has found that in focusing on taking better care of herself, she has actually gotten her mother to engage in some healthier choices and increased activity as well, making these lifestyle changes easier to implement.
Antecedents
According to Walker and Avant, 5 antecedents of a concept "must occur or be in place prior to the occurrence of the concept."
(p167) Two antecedents to the concept of depression in women with CHD are clear: (1) female gender and (2) a diagnosis of CHD. It has long been recognized that women are at an increased risk for depression compared with men. Women experience depression at a rate of roughly 2:1, beginning at menarche and continuing until menopause. The role of fluctuating levels of estrogen has been hypothesized as explaining this difference, since women's rates of depression begin to increase just as hormonal fluctuation begins and decline once these fluctuations cease. 23 Women are also more vulnerable to depressive symptoms prior to menstruation, following pregnancy, and during the perimenopausal period. 23 Depression in the CHD population is even more common than in the general population. Those who have had an MI experience depression at a rate of 17% to 27% (vs 10%-29% in the general population), and this rate is about twice as high in women with MI versus men. 2 The literature around depression in CHD also suggests that the magnitude of the precipitating cardiac event or severity of the disease does not equate to the emotional response. 24 In other words, a minor heart attack or only minor intervention does not mean a less dramatic emotional response. Likewise, a major Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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heart attack requiring a sizeable surgical intervention does not mean a more significant, deeper depressive response.
Several other possible antecedents for this concept of depression have also been described in the literature. These can be divided into 2 groups: physiological vulnerabilities, including genetics, younger age, presence of angina, and comorbid diabetes; and psychosocial vulnerabilities, including poor social support following a cardiac event, inability to return to work following the cardiac event, and comorbid anxiety (see Table 3 ).
Physiological vulnerabilities
Several authors have explored genetic vulnerability to depression in those with CHD. [25] [26] [27] Although an emerging area of scientific inquiry, these studies are beginning to elucidate a genetic link between depression and CHD. McCaffery and colleagues 27 cite several studies that suggest a possible common genetic "substrate" between CHD and depression and propose several candidate genes involving the inflammation and serotonin-mediated platelet aggregation pathway. Liu and colleagues, 26 in examining 7 possible single nucleotide polymorphisms on the brain-derived neurotrophic factor gene, were able to identify a single nucleotide polymorphism that demonstrated a significant association with CHD-induced depression. A twin study performed from the Swedish twin reg- 25 found a moderately strong genetic correlation between major depression and CHD, which is slightly higher in women than in men (+0.67 vs +0.62, respectively).
Several studies have indicated that younger women with CHD appear more vulnerable to developing depression than older women. 17, 28, 29 This may be due to younger women underestimating their risk for a cardiac event 17 or greater difficulty in adjusting to the uncertainties of a future that now includes a chronic illness in conjunction to the usual stressors of work and family roles. 29 Preand perimenopausal women will also still be vulnerable to fluctuating levels of hormones, as mentioned previously.
The presence of angina appears to be significantly associated with depression in those with CHD. 30, 31 Women, particularly American women, experience more angina than men. 32 Those who experienced angina consistently scored higher on depression assessment instruments than those who did not. 31 The study by Portillo et al 30 in Mexican American women showed that more women with angina experienced depression than women who did not have angina, and that this group also had significantly more problems with functional impairment (which may in turn exacerbate depressive symptoms). In the study by Jespersen et al, 31 angina was also significantly associated with anxiety.
Comorbidity with diabetes has also been strongly connected to depression in women with CHD in several studies. [33] [34] [35] Kronish et al, 34 in their study of acute coronary syndrome patients, noted that women with CHD and comorbid diabetes were more likely to report still being depressed 3 months after their cardiac incident than women without diabetes. The 12-month study by Murphy et al 35 of women after an acute cardiac event supports earlier finding by Kronish et al of a link between higher incidence of depression in women with comorbid diabetes. The study by Annunziato et al 33 found significantly elevated risk of depression as well as suicidality in individuals with CHD and comorbid Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. 
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Psychosocial vulnerabilities
Several psychosocial vulnerabilities have been identified in the literature regarding women with CHD and depression. Poor social support as a risk factor for depression in women following a cardiac event has been explored in several studies. [36] [37] [38] The work by Barefoot et al 37 examining the link between depression and social support found that those with CHD and poor social support exhibited higher levels of depression compared with those with good social support. Interestingly, social support seemed to be a bigger factor in depression among younger patients with CHD than older patients. The ENRICHD study, a groundbreaking study in the research of CHD and depression found that more than one-third (34%) of patients in the study experienced both depression and low-perceived social support, and these were predominantly women. 38 The 10-year literature review of Compare et al 36 examining the relationship between social support and depression in CHD patients (including marital relationships and social relationships) concluded that low levels of social support are an important risk factor for both development and worsening of depression.
Contrary to early hypotheses regarding work stress in women with CHD, research has shown that women who are unable to return to gainful employment experience more depression than those who are able to return to work. 39, 40 Blom and colleagues 39 examined 105 women of working age with CHD to determine the association between work and depressive symptoms. They concluded that women who were working demonstrated lower levels of depressive symptoms than those who were not, regardless of age, educational status, or risk factors for CHD (including diabetes). Work also increased the degree of social support experienced by these women. Boudrez and DeBacker 40 examined return to work in acute MI or coronary artery bypass graft patients. They found that, after 1 year, those who had returned to work demonstrated more positive affect, less negative affect, and fewer somatic complaints.
Anxiety has been shown to have significant co-occurrence with depression in both the general population and the CHD population and is a significant risk factor for developing depression. Murphy and colleagues 35 noted in their study, which followed women for 12 months after a cardiac event that those who had anxiety were more likely to also have depression than those who did not have anxiety. Doering and colleagues, 41 in their study spanning 3 continents, found that women with CHD who experienced depression were 50% more likely than men to report also having anxiety. Such is the degree of overlap that one of the 12 research planning conferences prior to the publication of DSM-V was dedicated entirely to the "comorbidity of depression and generalized anxiety disorder."
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Consequences
The consequences of both heart disease and depression in women are substantial. It has been clearly demonstrated that individuals with CHD and comorbid depression have both increased morbidity and increased mortality compared with those without depression. "Among women with MI or other forms of ischemic heart disease, depression is associated with an approximate 3-fold increased risk for death or subsequent cardiac events independent of severity of depression." 43 Shah and colleagues 44 found that depressed women, 55 years of age or younger, had substantially higher CHD comorbidity and worse prognosis. These findings stress the need for more research on CHD and psychosocial factors, particularly depression, in young women, who are often underrepresented in clinical studies of cardiovascular disease.
Women also experience significant alterations in role function, self-image, and self-management, including secondary risk E34 ADVANCES IN NURSING SCIENCE/OCTOBER-DECEMBER 2019 factor reduction. 34, 45 Perhaps most important of these secondary risk reduction practices is exercise. Evidence supports depressive symptom improvement with attendance at CR, regardless of the participant's gender. 46 However, those with depression are less likely to attend CR and less likely to complete CR if they do attend initially.
Empirical referents
Walker and Avant 5 define empirical referents as "classes or categories of actual phenomena that by their existence or presence demonstrate the occurrence of the concept itself." They are "a means by which you can recognize or measure [emphasis added] the defining characteristics or attributes . . . ." 5 As has been discussed, the screening instruments to measure the presence or absence of "depression" are not consistent in regard to which attributes are being measured, and prior work calls into question how much of these attributes are required to be clinically significant in this population. Therefore, these commonly used instruments in conjunction with their standard cutoff criteria appear inadequate when it comes to measuring depression in women with CHD.
CONCLUSIONS AND RELEVANCE TO CLINICAL PRACTICE
As previously stated, the purpose for this concept analysis was to clarify the concept of depression in women following a diagnosis of CHD. A better understanding of women's experiences of depressive symptoms in this population will allow more accurate diagnoses to be made and timely and appropriate interventions to be initiated. Based on this concept analysis, it appears that depression in women with CHD has been operationalized as a somatic and cognitive experience; only a cognitive experience; and as a pervasive affective, physical, and psychological experience, among many others. This concept analysis has illustrated the need to revisit these myriad operational definitions of depression as they pertain to this population in order to be more congruent with the conceptual definition as defined by DSM-V. Based on the literature reviewed for this analysis, women appear to experience both cognitive and somatic depressive symptoms but be more burdened by somatic symptoms than men and to experience depressive symptoms at higher rates than men. In addition, a specific group of symptoms (eg, tiredness/fatigue, appetite disturbance, concentration difficulties-see Table 2 ) has been identified as being the most common depressive symptoms in women with CHD. Further qualitative studies that lend support to this group of symptoms as being the most commonly experienced and germane symptoms in this population are recommended.
Women with CHD who present with antecedent conditions, including a significant family history of depression, younger age, angina, comorbid diabetes, poor social support, the inability to return to work, or comorbid anxiety, should be carefully monitored for the development of depression as these conditions have clearly been identified with an increased risk of depression. Women with CHD who present with somatic complaints need to be evaluated for possible depression, as these symptoms appear to be particularly salient to women's depressive experience and may also be perceived as "safer" to report, given the stigma still associated with mental illness by some. 21 Screening for depression in women with CHD is problematic due to the multiple instruments currently used to measure the concept. Careful consideration should be given to the assessment instrument being used. If an instrument with no somatic symptoms is chosen (such as HADS or PROMIS), some other means of capturing these symptoms needs to be utilized and justification needs to be offered if the instrument is being used for research purposes. When assessing this population, solely using MDD criteria to define who may need further evaluation may not be appropriate since this criterion is likely to miss a significant percentage of women who do in fact have depressive Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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symptoms that may lead to worse outcomes. Consideration should be given to using different cutoff scores on depressive symptom assessment instruments, such as those proposed by Strik et al, 16 Moullec et al, 47 and Haddad et al 48 when assessing this population.
Several instruments that were originally developed in noncardiac populations have been analyzed for use in the CHD population, including the BDI-I and BDI-II, the PHQ-9, and HADS. Usually, such analyses are performed to determine appropriateness for use in the population and/or optimal cutoff scores for detecting clinically significant depressive symptoms. However, these authors are unaware of any study that has compared the most used and/or recommended depressive symptom-screening instruments to a diagnostic interview specifically in women with CHD to determine which instrument has the best area under the curve (indicating the best sensitivity/specificity for detecting depression in the population). This is a significant gap in our ability to accurately assess women with CHD.
However, thinking in the psychiatric community seems to be shifting away from the previously embraced "prescriptive" approach to diagnosis. The shortcomings of drawing hard boundaries between mental health diagnoses and the significant overlap between such conditions as anxiety and depression have forced what feels like another paradigm shift in mental health. There is no clear consensus on the definition of depression. In a 2017 editorial, Stringaris 49 noted that "psychi- He notes the questionable coefficient κ (a statistic of agreement between raters) for adults in the DSM reliability field trials, situation-bound changes, the question of depressive subtypes, and the concern of overpathologizing normal low mood responses.
Still, it is undisputable that poor outcomes in women with CHD are associated with the group of symptoms we currently call "depression." The cost in terms of time and money and availability of resources for long diagnostic interviews will no doubt continue to prevent them from being routinely used in research or primary care settings. Until such time as technology (such as computeradaptive testing or artificial intelligence) makes screening instruments obsolete and/or the very definition of depression is rewritten, depression-screening instruments will continue to be used in both research and clinical settings. This analysis clarifies the concept of depression in women with CHD and outlines its defining attributes along with its antecedents and consequences. A model case, along with borderline and contrary cases, is provided to make identification of this concept clear. In conclusion, as CHD research moves forward, researchers and clinicians need to be cognizant of utilizing instruments that operationalize the concept of depression in women with CHD as presented in this concept analysis.
